PRESS RELEASE published on 11/20/2024 at 22:00, 4 days 13 hours ago Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024 Inventiva reports total voting rights and shares as of November 4, 2024, in accordance with Article R. 22-10-23 of the French Commercial Code. The company is a clinical-stage biopharmaceutical with a focus on oral small molecule therapies Shares Total Voting Rights Clinical-Stage Biopharmaceutical Inventiva MASH/NASH
PRESS RELEASE published on 11/20/2024 at 22:00, 4 days 13 hours ago Combined General Meeting of December 11, 2024 - Availability of the preparatory documents Inventiva announces availability of preparatory documents for Combined General Meeting on December 11, 2024. Shareholders can participate in person or request documents electronically. Detailed resolutions and meeting information provided Shareholders Resolutions Preparatory Documents Combined General Meeting Inventiva
PRESS RELEASE published on 11/20/2024 at 21:13, 4 days 14 hours ago Inside Information / Other news releases CD&R and Permira announce regulatory clearances for the acquisition of majority stake in Exclusive Networks and launch of tender offer Acquisition Tender Offer Exclusive Networks CD&R Permira
PRESS RELEASE published on 11/20/2024 at 21:00, 4 days 14 hours ago Japanese Wagyu Promotion Launched November 15th in the U.S. The 5th annual Japanese Wagyu campaign, 'Deep Dive into the Wonders of Japanese Wagyu -Farm to Our Table-' showcases farming craftsmanship and partnerships with restaurants in NYC, LA, San Francisco & Miami Partnerships Campaign Japanese Wagyu Farming Restaurants
PRESS RELEASE published on 11/20/2024 at 20:30, 4 days 15 hours ago Dr. Bill Releford and Los Angeles Rams Partner to Empower Community Health and Wellness Dr. Bill Releford partners with Los Angeles Rams to promote health and wellness in Southern California communities through educational programs and community events Partnership Health And Wellness Community Outreach Los Angeles Rams Dr. Bill Releford
PRESS RELEASE published on 11/20/2024 at 19:45, 4 days 16 hours ago TGL Presented by SoFi Names SYNLawn As Official Synthetic Surface Partner, Providing 31,000 Square Feet of Turf for SoFi Center’s Tech-Infused Field of Play SYNLawn becomes the 11th official partner of TGL presented by SoFi, providing synthetic turf solutions for prime time golf league featuring PGA TOUR stars. Innovative partnership enhances playing conditions at SoFi Center Golf Partnership SYNLawn TGL SoFi
REGULATED PRESS RELEASE published on 11/20/2024 at 19:20, 4 days 16 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting Peugeot Invest Board to evolve post May 2025 AGM: Édouard Peugeot named Non-Executive Chairman, Robert Peugeot Honorary Chairman. Selection process led by Governance Committee Board Of Directors PEUGEOT INVEST Robert Peugeot Governance Committee Édouard Peugeot
PRESS RELEASE published on 11/20/2024 at 19:19, 4 days 16 hours ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces purchase of 180,000 ordinary shares for cancellation at prices ranging from 126.00p to 128.00p each on the London Stock Exchange London Stock Exchange Ordinary Shares Share Price Cancellation Funding Circle Holdings PLC
PRESS RELEASE published on 11/20/2024 at 19:00, 4 days 16 hours ago 19 Year Old Debuts Poetry Book, Becomes Bestseller Ahead of The Holidays Madi James Stearman, a 19-year-old author, released 'There's Beauty in the Breakdown', a bestseller featuring raw poetry on life struggles and growth. Published by Landon Hail Press Bestseller Landon Hail Press Madi James Stearman There's Beauty In The Breakdown Raw Poetry
PRESS RELEASE published on 11/20/2024 at 18:38, 4 days 17 hours ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 2,500 'A' ordinary shares at an average price of 694.0000 GBp each, as part of its share buyback programme Voting Rights London Stock Exchange Share Buyback Numis Securities Limited Fuller Smith Turner PLC
Published on 11/25/2024 at 11:00, 55 minutes ago PV ModuleTech Conference Europe to Share Latest Trends in Solar Module Buying
Published on 11/25/2024 at 11:00, 55 minutes ago QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
Published on 11/25/2024 at 09:15, 2 hours 40 minutes ago Troy Minerals Completes LiDAR Survey at Table Mountain Silica Project, British Columbia
Published on 11/25/2024 at 09:05, 2 hours 50 minutes ago BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity
Published on 11/25/2024 at 04:00, 7 hours 55 minutes ago Tanzania Safaris Unveils New Luxury Adventure Packages for 2025
Published on 11/25/2024 at 11:39, 15 minutes ago SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry
Published on 11/25/2024 at 11:17, 37 minutes ago Thrive Renewables Plc 2024 Half Year Results for the period ended 30 June 2024
Published on 11/25/2024 at 10:54, 1 hour ago AGRANA presents extensive product portfolio for the food and beverage sector at Food Ingredients Europe
Published on 11/25/2024 at 10:00, 1 hour 55 minutes ago Wolftank Group further strengthens hydrogen positioning with new orders totaling EUR 10 million
Published on 11/25/2024 at 09:49, 2 hours 5 minutes ago New CFO for Advanced Blockchain AG: Maik Laske brings 30 years of financial expertise to the leadership team
Published on 11/25/2024 at 08:00, 3 hours 55 minutes ago EURAZEO RAISES A €180 MILLION CONTINUATION FUND TO SUPPORT I-TRACING AND ITS MANAGEMENT TEAM IN THE NEXT PHASE OF GROWTH
Published on 11/21/2024 at 06:58, 4 days 4 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 16 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 18 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM